Novartis | NVS - Ordinary Share Capital

Stock Price
154.03
Daily Change
-1.14 -0.73%
Monthly
-6.21%
Yearly
37.12%
Q2 Forecast
144.45

Novartis reported $1.91B in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Amgen USD 539M 1000K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Bausch Health Companies USD 370.53M 59K Dec/2025
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 368.28M 35.9M Dec/2025
Corcept Therapeutics USD 105.97M 842K Dec/2025
Drreddys Laboratories INR 832.57M 53K Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Glaxosmithkline GBP 4.08B 49.43M Dec/2025
J&J USD 2.41B 584K Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Novartis USD 1.91B 10.64M Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Pacira USD 41.12M 1.85M Dec/2025
Perrigo USD 137.6M 0 Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Phibro Animal Health USD 40.48M 0 Dec/2025
Prestige Brands USD 48.08M 47.52M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
Zoetis USD 424.93M 16.54M Dec/2025